Uflex Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 5 Aug 2026 | Industrial Products | Market Cap: ₹3.4K Cr
The company expects around 5% revenue growth for the full FY'26 year, revised down from an earlier 10% projection. For FY'26, revenue growth is revised to around 5% with EBITDA expected between Rs.
From Uflex Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹615
Market Cap
₹3.4K Cr
P/E Ratio
10.4
How does Uflex Ltd rank in Industrial Products?
Compare Uflex Ltd against every Industrial Products company this quarter on revenue, margins and earnings-call signals.
Uflex Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹3.6K Cr, net profit ₹36 Cr.
Full financials →📊 Revenue & Sales Performance
- →The company expects around 5% revenue growth for the full FY'26 year, revised down from an earlier 10% projection.
- →For FY'27, a 10% growth in revenue is anticipated, contingent on timely commissioning of new projects.
- →Sales volume for H1 FY'26 was 5.4% higher compared to the previous year.
- →Aseptic packaging units recorded highest-ever volumes during H1 FY'26 with 5.5% YOY growth.
- →New packaging film line at Dharwad (BOPP facility, 54,000 TPA) and three other projects (PET recycling in Noida, WPP and aseptic in Egypt and Mexico) expected to drive growth.
- →Full year EBITDA is expected between Rs. 1,800 to 1,850 crores for FY'26, slightly better than last year.
- →Growth and margin improvements expected as new capacities come online, mainly in FY'27 and beyond.
- →Seasonality impacts volumes, with higher utilization expected during peak seasons from January to August.
📈 Profitability & Margins
- →For FY'26, revenue growth is revised to around 5% with EBITDA expected between Rs. 1,800 to 1,850 crores, slightly better than FY'25's EBITDA of ~Rs. 1,700 crores.
- →FY'27 outlook suggests a clearer picture once new projects get commissioned, with potential 10% revenue growth depending on project timelines.
- →New capacities (BOPP lines by 2027, BOPET plant by 2028) are expected to support growth despite concerns of overcapacity.
- →EBITDA expected to improve substantially in FY'27 and beyond due to commissioning of new plants (PET recycling, aseptic facilities in Egypt and Mexico, WPP plant).
- →Debt reduction plan targets Rs. 500 crore repayment by FY'27, with net debt-to-EBITDA ratio around 2.8-3x post new investments.
- →The company is focusing on staying relevant and capturing long-term gains by timely capacity expansion despite short-term market cycles.
🏗️ Capital Expenditure Plans
- →UFLEX is setting up a new BOPP film line at Dharwad with a capacity of 54,000 tons per year, as part of an agreement with the state government involving tax concessions.
- →Four projects are in advanced stages, with expected commissioning by Q1 FY'27: India aseptic facility (already commissioned), PET recycling plant in Noida (expected operational by March 2026), WPP project, and aseptic facility in Egypt.
- →Additional capital expenditure of approximately Rs. 950 crores is expected by FY'27 to complete ongoing projects.
- →Management highlighted the possibility of investments in the next couple of years but prefers using cash on the balance sheet rather than raising further debt.
- →New capacities in BOPP and BOPET films are expected by FY'27 and FY'28 respectively, with 1 lakh TPA BOPP capacity coming in FY'27.
- →No immediate plans for equity raising at the parent company level; possibility at subsidiary level exists but not soon.
💰 Fundraising & Capital Structure
- →No new equity raising is planned at the company level due to the current promoter family shareholding structure.
- →Equity fundraising might be possible at the subsidiary level but is considered a distant possibility and not imminent.
- →Additional debt of around Rs. 950 crores is expected in FY'27 to complete ongoing projects.
- →About Rs. 1,500 crores of existing debt will be repaid by March FY'27, resulting in a net reduction of Rs. 500 crores in debt.
- →The company aims to reduce net debt from approx. Rs. 7,750 crores currently to around Rs. 7,300 crores by FY'27.
- →Debt-to-EBITDA ratio is expected to be around 2.8x to 3x considering EBITDA growth and current debt levels.
- →The company was exploring listing about three years ago but market conditions and business performance did not support equity raising at that time.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Uflex Ltd Q2 FY26 results?
The company expects around 5% revenue growth for the full FY'26 year, revised down from an earlier 10% projection. For FY'26, revenue growth is revised to around 5% with EBITDA expected between Rs.
What is Uflex Ltd share price analysis?
Uflex Ltd currently shows a neutral. The stock trades at a P/E of 10.4 with a market cap of ₹3,437 Cr. Investors should review the full earnings analysis for detailed insights.
Is Uflex Ltd planning capital expenditure?
UFLEX is setting up a new BOPP film line at Dharwad with a capacity of 54,000 tons per year, as part of an agreement with the state government involving tax concessions. - Four projects are in advanced stages, with expected commissioning by Q1 FY'27: India aseptic facility (already commissioned), PET recycling plant in Noida (expected operational by March 2026), WPP project, and aseptic facility in Egypt. - Additional capital expenditure of approximately Rs.
Keep Uflex Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.